SPRING, Texas, July 13, 2026 /PRNewswire/ -- TETRA Technologies, Inc. (NYSE:TTI) will release Second

San Diego, California--(Newsfile Corp. - July 13, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI

Tvardi Therapeutics, Inc. (TVRD) Discusses Phase 1 Data on TTI-109 STAT3 Inhibitor Highlighting Prod

TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions i

Northland Capital Markets analyst Bobby Brooks maintains Tetra Technologies (NYSE:TTI) with a Out

Tetra Technologies (TTI) was a big mover last session on higher-than-average trading volume. The lat

Using Neptune Chemistry to Achieve Required Density With Lower Zinc Content; Awarded Three-Well 20k

Using Neptune Chemistry to Achieve Required Density With Lower Zinc Content; Awarded Three-Well 20k

TETRA Technologies, Inc. (TTI) Presents at J.P. Morgan Natural Resources Conference 2026 Transcript

San Diego, California--(Newsfile Corp. - June 17, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI

VIAV's new TETRA testing upgrade for the CX300 aims to speed deployments, cut costs, and reinforce i

Allows full testing of TETRA MS radios, including transmitter parametric measurements, call processi

Hallead acquired 22,000 shares on June 9, 2026, at a weighted average price of $9.86 per share, repr

San Diego, California--(Newsfile Corp. - June 3, 2026) - Thiogenesis Therapeutics Corp. (TSXV: TTI)

Tetra Technologies Inc. (NYSE: TTI) shares fell 15.06% in pre-market trading after announcing a $100

TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) today announced the p

TETRA Technologies, Inc. Announces Pricing of Public Offering of Common Stock PR Newswire SPRING, Te

SPRING, Texas, June 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYS

TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) today announced the c

SPRING, Texas, June 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYS

San Diego, California--(Newsfile Corp. - June 1, 2026) - Thiogenesis Therapeutics Corp. (TSXV: TTI) 

Phase 1 of the Evergreen Project, which included site preparation, power infrastructure, and install

"The Board's approval of the final investment decision for our Arkansas bromine facility mar

Strong Project Economics and Growth Outlook With a Secure U.S. Bromine Supply SPRING, Texas, May 28,

San Diego, California--(Newsfile Corp. - May 11, 2026) - Thiogenesis Therapeutics Corp. (TSXV: TTI)

TETRA Technologies reported decade-high Q1 2026 revenue and EBITDA, with EPS coming 100% above estim

Topline results from healthy volunteer study and clinical development strategy  for next-generation

Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for it

Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss

Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterl

Companies Reporting Before The Bell • Insperity (NYSE:NSP) is estimated to report quarterly earning

During Thursday's morning session, 33 stocks hit new 52-week lows.

Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Wednesday